☆ 4.8 Review

Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Letter Dermatology

Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies

Michael Kasperkiewicz et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Review Rheumatology

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations

Feline P. B. Kroon et al.

Summary: This systematic literature review on patients with rheumatic and musculoskeletal diseases (RMDs) examined the risk and prognosis of SARS-CoV-2 infection as well as the vaccination against SARS-CoV-2. Most studies indicated that individuals with RMDs do not have a higher risk of contracting SARS-CoV-2 or experiencing worse COVID-19 outcomes compared to those without RMDs. Disease activity and medication use may influence the prognosis of COVID-19.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Dermatology

Evidence for a role of extracellular heat shock protein 70 in epidermolysis bullosa acquisita

Stefan Tukaj et al.

Summary: The study revealed the previously unknown role of extracellular Hsp70 in epidermolysis bullosa acquisita (EBA) and suggested it as a potential treatment target. Experimental findings indicated that Hsp70 may exacerbate the clinical severity of EBA by promoting inflammatory responses and oxidative stress.

EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Letter Dermatology

Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19

M. Kasperkiewicz et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Add to Collection

Article Physiology

HSP90 Inhibitors Modulate SARS-CoV-2 Spike Protein Subunit 1-Induced Human Pulmonary Microvascular Endothelial Activation and Barrier Dysfunction

Ruben Manuel Luciano Colunga Biancatelli et al.

Summary: Studies have shown that the spike protein subunit 1 of SARS-CoV-2 can directly damage endothelial cells and cause endothelial barrier dysfunction. Inhibitors of heat shock protein 90 have been found to prevent and repair this damage.

FRONTIERS IN PHYSIOLOGY (2022)

Add to Collection

Article Immunology

Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita

Stefan Tukaj et al.

Summary: Stress-induced heat shock protein 70 (Hsp70) plays a crucial role in autoimmune processes, with highly immunogenic extracellular Hsp70 activating immune responses and contributing to the development of inflammatory/autoimmune disorders. Anti-Hsp70 autoantibodies are significantly increased in patients with epidermolysis bullosa acquisita (EBA), an autoimmune blistering skin disease, and are positively correlated with pro-inflammatory interferon gamma (IFN-γ) levels. These autoantibodies promote EBA development by enhancing neutrophil infiltration and activating the NF-κB signaling pathway in an IFN-γ-associated manner.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Letter Infectious Diseases

Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants

Abdo A. Elfiky et al.

JOURNAL OF INFECTION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases

Stefan Tukaj et al.

Summary: Over a hundred different autoimmune diseases have been described to date, affecting various organs including the skin. The loss of immune tolerance in autoimmune diseases leads to chronic inflammation and tissue damage. Current treatments focus on immunosuppression but may cause serious adverse effects. Heat shock proteins Hsp90 and Hsp70 have been identified as potential therapeutic targets for autoimmune skin diseases.

BIOMOLECULES (2022)

Add to Collection

Review Medicine, Research & Experimental

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Chen Hu et al.

Summary: Heat shock proteins (HSPs) play important roles in cellular protection and have various functions, such as molecular chaperones and involvement in protein folding and cell signaling. They are associated with multiple diseases, and recent studies have focused on understanding their molecular mechanisms and potential therapeutic applications.

MEDCOMM (2022)

Add to Collection

Letter Cell Biology

Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention

Michael Kasperkiewicz

Summary: A potential link between Covid-19 and the development of autoimmune diseases has been suggested, possibly due to molecular similarities between SARS-CoV-2 and human proteins. Research has shown shared peptides between antigenic epitopes of the virus and heat shock proteins, indicating a possible autoimmune response.

CELL STRESS & CHAPERONES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 infection remodels the host protein thermal stability landscape

Joel Selkrig et al.

Summary: Understanding how SARS-CoV-2 manipulates host cellular machinery on a system-wide scale is crucial for developing host-directed therapies. In this study, temporal alterations in host protein thermostability during infection were observed, converging on cellular processes such as cell cycle regulation. Pharmacological inhibition of host proteins with altered thermal stability or abundance could suppress SARS-CoV-2 replication.

MOLECULAR SYSTEMS BIOLOGY (2021)

Add to Collection

Article Genetics & Heredity

SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene

Jibran Sualeh Muhammad et al.

Summary: This study identified potential candidate genes that may be regulated by SARS-CoV-2 induced DNA methylation changes in COVID-19 infection, emphasizing the importance of epigenetic effects in this process.

FRONTIERS IN GENETICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy

Emanuel Wyler et al.

Summary: Detailed analysis of SARS-CoV-2 infection in comparison with SARS-CoV reveals a stronger induction of innate immune response, including the upregulation of miRNA-155. Infected cells show broad upregulation of genes, while interferon beta/lambda genes and pro-inflammatory cytokines like IL-6 are expressed in only a small subset of cells. Time analysis suggests that interferon regulatory factors are activated before nuclear factor kappa B in response to infection, with heat shock protein 90 (HSP90) identified as a relevant protein for viral replication and inflammatory cytokine expression.

ISCIENCE (2021)

Add to Collection

Article Cell Biology

Morphological Alterations and Stress Protein Variations in Lung Biopsies Obtained from Autopsies of COVID-19 Subjects

Rosario Barone et al.

Summary: Molecular chaperones, particularly Hsp60 and Hsp90, play a role in COVID-19-related lung damage and may be associated with thromboembolic events contributing to death. Further research on a larger scale is needed to confirm these findings and identify potential new biomarkers for combating the disease.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection

Anthony J. Carlos et al.

Summary: In addition to ACE2, GRP78 may play a significant role in SARS-CoV-2 infection as an important host auxiliary factor. Inhibition of GRP78 can reduce ACE2 expression and inhibit viral entry and infection.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Article Medicine, General & Internal

Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens

Michael Kasperkiewicz et al.

Summary: This study investigated 24 individuals who recovered from COVID-19 and received the Pfizer-BioNTech COVID-19 vaccine, and found that none of them showed antibody reactivity to any tested autoantigens. Therefore, the study suggests that there is no relationship between SARS-CoV-2 infection/vaccines and AIBDs in terms of disease-triggering antibody cross-reactivity.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells

Ria Goswami et al.

Summary: Current SARS-CoV-2 therapeutics target moderately to severely ill patients, with limited options for those with mild symptoms. Vaccine hesitancy and distribution challenges hinder the pandemic's end. There is a need for easily administrable therapeutics to prevent disease progression.

ISCIENCE (2021)

Add to Collection

Article Cell Biology

Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms

Jagoda Mantej et al.

Summary: The study did not find evidence of autoimmunity against extracellular heat shock proteins caused by SARS-CoV-2, but further testing for cell-based immunity is needed for a complete evaluation of this hypothesis.

CELL STRESS & CHAPERONES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection

Anna Lubkowska et al.

Summary: Heat shock proteins (HSPs) are important molecular chaperones found in most eukaryotes and bacteria, responsible for maintaining cell homeostasis and assisting viral replication. HSP70 and HSP90 families are crucial for folding and replicating viral proteins, highlighting their potential in antiviral therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Infectious Diseases

COVID-19 spike-host cell receptor GRP78 binding site prediction

Ibrahim M. Ibrahim et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity

Stefan Tukaj

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Immunology

Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target

Cun Li et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Review Medicine, General & Internal

Pemphigus

Enno Schmidt et al.

LANCET (2019)

Add to Collection

Article Dermatology

Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation

Stefan Tukaj et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases

Stefan Tukaj et al.

EXPERIMENTAL DERMATOLOGY (2015)

Add to Collection

Article Dermatology

Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita

Stefan Tukaj et al.

EXPERIMENTAL DERMATOLOGY (2015)

Add to Collection

Article Cell Biology

Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes

Stefan Tukaj et al.

CELL STRESS & CHAPERONES (2014)

Add to Collection

Article Dermatology

Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses

Stefan Tukaj et al.

EXPERIMENTAL DERMATOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Pemphigoid diseases

Enno Schmidt et al.

LANCET (2013)

Add to Collection

Article Multidisciplinary Sciences

Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid

Stefan Tukaj et al.

PLOS ONE (2013)

Add to Collection

Article Hematology

Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets

Michael Kasperkiewicz et al.

BLOOD (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.